1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SUPERNUS PHARMACEUTICALS INC
Supernus Pharmaceuticals Inc XNAS: SUPN

Supernus Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

Read More
44.80 0.81 (1.84%)
Near 52W High of $46.78
625.3K
XNAS Volume

XNAS 17 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Supernus Pharmaceuticals Inc is on 18 Sep 2025 for the purpose of TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit See details
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Affordable Valuation
51.2 / 100
Momentum Score
Technically Moderately Bullish
62.0 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors. View Similar Embed DVM
Analyst Price Target
44
1Yr Price target downside is -2%
5 analysts

20

S

1

W

0

O

2

T

SWOT Analysis

Supernus Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..